6YTY image
Entry Detail
PDB ID:
6YTY
Keywords:
Title:
CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-04-24
Release Date:
2020-07-15
Method Details:
Experimental Method:
Resolution:
1.76 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
I 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Dual specificity protein kinase CLK3
Mutations:A319V
Chain IDs:A
Chain Length:360
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity.
J.Med.Chem. 63 10224 10234 (2020)
PMID: 32787076 DOI: 10.1021/acs.jmedchem.0c00898

Abstact

Selectivity remains a challenge for ATP-mimetic kinase inhibitors, an issue that may be overcome by targeting unique residues or binding pockets. However, to date only few strategies have been developed. Here we identify that bulky residues located N-terminal to the DFG motif (DFG-1) represent an opportunity for designing highly selective inhibitors with unexpected binding modes. We demonstrate that several diverse inhibitors exerted selective, noncanonical binding modes that exclusively target large hydrophobic DFG-1 residues present in many kinases including PIM, CK1, DAPK, and CLK. By use of the CLK family as a model, structural and biochemical data revealed that the DFG-1 valine controlled a noncanonical binding mode in CLK1, providing a rationale for selectivity over the closely related CLK3 which harbors a smaller DFG-1 alanine. Our data suggest that targeting the restricted back pocket in the small fraction of kinases that harbor bulky DFG-1 residues offers a versatile selectivity filter for inhibitor design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures